Certified by Founder Lodge
Novalis Biotech
Belgium - Ghent, Flemish Region
INVESTOR
1 Disclosed Funding Rounds $1,000,000
1 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Novalis Biotech is an early stage venture capital fund in life sciences, focusing on enabling technologies in healthcare, such as digital health, diagnostics, genomics and bio-informatics.
| Company | Date | Round | Raised |
|---|---|---|---|
 Alithea Genomics |
May, 24 ,2022 | Seed | $1,000,000 |
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Manufact (formerly mcp-use) | $6,300,000 | (Feb 13, 2026)
CYDELPHI | $3,000,000 | (Feb 13, 2026)
Integrate | $17,000,000 | (Feb 13, 2026)
Maestro Tech, Inc. | $1,200,000 | (Feb 13, 2026)
Reflow | $15,000,000 | (Feb 13, 2026)
